Antiplatelet effects of natural bioactive compounds by multiple targets: Food and drug interactions

Journal of Functional Foods

Volumn 6, Issue 1, 2014, Pages 73-81

  Fuentes, Eduardo ^a,b   Palomo, Iván ^a,b  

^a UNIVERSIDAD DE TALCA   (Chile)

^b Centro de Estudios en Alimentos Procesados (CEAP)   (Chile)

Author keywords

Antiplatelet; Functional foods; Multiple targets; Natural bioactive compounds

Indexed keywords

EID: 84895068034     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2013.10.012     Document Type: Review

References (131)

1. Adams M.R., Golden D.L., Chen H., Register T.C., Gugger E.T. A diet rich in green and yellow vegetables inhibits atherosclerosis in mice. Journal of Nutrition 2006, 136:1886-1889.
2. Akbar H., Navran S.S., Chang J., Miller D.D., Feller D.R. Investigation of the effects of phospholipase C on human platelets: Evidence that aggregation induced by phospholipase C is independent of prostaglandin generation, released ADP and is modulated by cyclic AMP. Thrombosis Research 1982, 27:405-417.
3. Ali F.Y., Hall M.G., Desvergne B., Warner T.D., Mitchell J.A. PPARbeta/delta agonists modulate platelet function via a mechanism involving PPAR receptors and specific association/repression of PKCalpha - Brief report. Arteriosclerosis, Thrombosis, and Vascular Biology 2009, 29:1871-1873.
4. Allison G.L., Lowe G.M., Rahman K. Aged garlic extract inhibits platelet activation by increasing intracellular cAMP and reducing the interaction of GPIIb/IIIa receptor with fibrinogen. Life Sciences 2012, 91:1275-1280.
5. Altman R., Rouvier J., Weisenberger H. Identification of platelet inhibitor present in the melon (Cucurbitaceae cucumis melo). Thrombosis and Haemostasis 1985, 53:312-313.
6. Anfossi G., Russo I., Massucco P., Mattiello L., Cavalot F., Balbo A., Trovati M. Adenosine increases human platelet levels of cGMP through nitric oxide: Possible role in its antiaggregating effect. Thrombosis Research 2002, 105:71-78.
7. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002, 324:71-86. Antithrombotic Trialists' Collaboration.
8. Angiolillo D.J. Variability in responsiveness to oral antiplatelet therapy. American Journal of Cardiology 2009, 103:27A-34A.
9. Atsushi O. Anti-platelets effects of genistein, an isoflavonoid from soybean. Soy Protein Research 2004, 7:145-148.
10. Barrett N.E., Holbrook L., Jones S., Kaiser W.J., Moraes L.A., Rana R., Sage T., Stanley R.G., Tucker K.L., Wright B., Gibbins J.M. Future innovations in anti-platelet therapies. British Journal of Pharmacology 2008, 154:918-939.
11. Beretz A., Stierle A., Anton R., Cazenave J.P. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin. Biochemical Pharmacology 1982, 31:3597-3600.
12. 2+ mobilization and granule secretion in platelets. Journal of Biological Chemistry 1985, 260:15172-15179.
13. Campbell S.E., Stone W.L., Whaley S.G., Qui M., Krishnan K. Gamma (gamma) tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma (gamma) expression in SW 480 human colon cancer cell lines. BMC Cancer 2003, 3:25.
14. Cavagnaro P.F., Camargo A., Galmarini C.R., Simon P.W. Effect of cooking on garlic (Allium sativum L.) antiplatelet activity and thiosulfinates content. Journal of Agriculture and Food Chemistry 2007, 55:1280-1288.
15. Chackalamannil S., Davies R.J., Wang Y., Asberom T., Doller D., Wong J., Leone D., McPhail A.T. Total Synthesis of (+)-Himbacine and (+)-Himbeline. Journal of Organic Chemistry 1999, 64:1932-1940.
16. Chackalamannil S., Xia Y., Greenlee W.J., Clasby M., Doller D., Tsai H., Asberom T., Czarniecki M., Ahn H.S., Boykow G., Foster C., Agans-Fantuzzi J., Bryant M., Lau J., Chintala M. Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agents. Journal of Medicinal Chemistry 2005, 48:5884-5887.
17. Chang S.S., Lee V.S., Tseng Y.L., Chang K.C., Chen K.B., Chen Y.L., Li C.Y. Gallic acid attenuates platelet activation and platelet-leukocyte aggregation: involving pathways of Akt and GSK3beta. Evidence-Based Complementary and Alternative Medicine 2012, 2012:683872.
18. Chang C.C., Lu W.J., Chiang C.W., Jayakumar T., Ong E.T., Hsiao G., Fong T.H., Chou D.S., Sheu J.R. Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase. Journal of Nutritional Biochemistry 2010, 21:1214-1221.
19. Chang C.C., Lu W.J., Ong E.T., Chiang C.W., Lin S.C., Huang S.Y., Sheu J.R. A novel role of sesamol in inhibiting NF-kappaB-mediated signaling in platelet activation. Journal of Biomedical Science 2011, 18:93.
20. Chiu H.F., Yang S.P., Kuo Y.L., Lai Y.S., Chou T.C. Mechanisms involved in the antiplatelet effect of C-phycocyanin. British Journal of Nutrition 2006, 95:435-440.
21. Cho H.J., Cho J.Y., Rhee M.H., Lim C.R., Park H.J. Cordycepin (3'-deoxyadenosine) inhibits human platelet aggregation induced by U46619, a TXA2 analogue. Journal of Pharmacy and Pharmacology 2006, 58:1677-1682.
22. Cho H.J., Cho J.Y., Rhee M.H., Park H.J. Cordycepin (3'-deoxyadenosine) inhibits human platelet aggregation in a cyclic AMP- and cyclic GMP-dependent manner. European Journal of Pharmacology 2007, 558:43-51.
23. Cho H.J., Kang H.J., Kim Y.J., Lee D.H., Kwon H.W., Kim Y.Y., Park H.J. Inhibition of platelet aggregation by chlorogenic acid via cAMP and cGMP-dependent manner. Blood Coagulation & Fibrinolysis 2012, 23:629-635.
24. Chou T.C., Shih C.Y., Chen Y.T. Inhibitory effect of alpha-lipoic acid on platelet aggregation is mediated by PPARs. Journal of Agriculture and Food Chemistry 2011, 59:3050-3059.
25. Chuang W.Y., Kung P.H., Kuo C.Y., Wu C.C. Sulforaphane prevents human platelet aggregation through inhibiting the phosphatidylinositol 3-kinase/Akt pathway. Thrombosis and Haemostasis 2013, 109.
26. Coccheri S. Antiplatelet drugs-do we need new optionsα With a reappraisal of direct thromboxane inhibitors. Drugs 2010, 70:887-908.
27. Cook N., Nahorski S.R., Jagger C., Barnett D.B. Is the human platelet beta 2 adrenoceptor coupled to adenylate cyclaseα. Naunyn Schmiedebergs Arch Pharmacol 1988, 337:238-240.
28. Das L., Bhaumik E., Raychaudhuri U., Chakraborty R. Role of nutraceuticals in human health. Journal of Food Science and Technology 2012, 49:173-183.
29. Davi G., Patrono C. Platelet activation and atherothrombosis. New England Journal of Medicine 2007, 357:2482-2494.
30. Dell'Agli M., Maschi O., Galli G.V., Fagnani R., Dal Cero E., Caruso D., Bosisio E. Inhibition of platelet aggregation by olive oil phenols via cAMP-phosphodiesterase. British Journal of Nutrition 2008, 99:945-951.
31. Duttaroy A.K., Jorgensen A. Effects of kiwi fruit consumption on platelet aggregation and plasma lipids in healthy human volunteers. Platelets 2004, 15:287-292.
32. el-Feraly F.S., Chan Y.M. Isolation and characterization of the sesquiterpene lactones costunolide, parthenolide, costunolide diepoxide, santamarine, and reynosin from Magnolia grandiflora L. Journal of Pharmaceutical Sciences 1978, 67:347-350.
33. Freedman J.E., Farhat J.H., Loscalzo J., Keaney J.F. Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 1996, 94:2434-2440.
34. Fuentes E.J., Astudillo L.A., Gutierrez M.I., Contreras S.O., Bustamante L.O., Rubio P.I., Moore-Carrasco R., Alarcon M.A., Fuentes J.A., Gonzalez D.E., Palomo I.F. Fractions of aqueous and methanolic extracts from tomato (Solanum lycopersicum L.) present platelet antiaggregant activity. Blood Coagulation & Fibrinolysis 2012, 23:109-117.
35. Fuentes E., Carle R., Astudillo L., Guzman L., Gutierrez M., Carrasco G., Palomo I. Antioxidant and antiplatelet activities in extracts from green and fully ripe tomato fruits (Solanum lycopersicum) and pomace from industrial tomato processing. Evidence-Based Complementary and Alternative Medicine 2013, 2013:867578.
36. Fuentes E., Castro R., Astudillo L., Carrasco G., Alarcón M., Gutiérrez M., Palomo I. Bioassay-guided isolation and HPLC determination of bioactive compound that relate to the antiplatelet activity (adhesion, secretion, and aggregation) from Solanum lycopersicum. Evidence-Based Complementary and Alternative Medicine 2012, 1-10.
37. Fukao H., Yoshida H., Tazawa Y., Hada T. Antithrombotic effects of odorless garlic powder both in vitro and in vivo. Bioscience, Biotechnology, and Biochemistry 2007, 71:84-90.
38. Gottstein N., Ewins B.A., Eccleston C., Hubbard G.P., Kavanagh I.C., Minihane A.M., Weinberg P.D., Rimbach G. Effect of genistein and daidzein on platelet aggregation and monocyte and endothelial function. British Journal of Nutrition 2003, 89:607-616.
39. Gresele P., Momi S., Falcinelli E. Anti-platelet therapy: Phosphodiesterase inhibitors. British Journal of Clinical Pharmacology 2011, 72:634-646.
40. Griffiths J.C., Abernethy D.R., Schuber S., Williams R.L. Functional food ingredient quality: Opportunities to improve public health by compendial standardization. Journal of Functional Foods 2009, 1:128-130.
41. Guerrero J.A., Lozano M.L., Castillo J., Benavente-Garcia O., Vicente V., Rivera J. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor. Journal of Thrombosis and Haemostasis 2005, 3:369-376.
42. Guidetti G.F., Bernardi B., Consonni A., Rizzo P., Gruppi C., Balduini C., Torti M. Integrin alpha2beta1 induces phosphorylation-dependent and phosphorylation-independent activation of phospholipase Cgamma2 in platelets: Role of Src kinase and Rac GTPase. Journal of Thrombosis and Haemostasis 2009, 7:1200-1206.
43. Hasler C., Kundrat S., Wool D. Functional foods and cardiovascular disease. Current Atherosclerosis Reports 2000, 2:467-475.
44. Holy E.W., Forestier M., Richter E.K., Akhmedov A., Leiber F., Camici G.G., Mocharla P., Luscher T.F., Beer J.H., Tanner F.C. Dietary alpha-linolenic acid inhibits arterial thrombus formation, tissue factor expression, and platelet activation. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:1772-1780.
45. Hsiao G., Chang C.Y., Shen M.Y., Chou D.S., Tzeng S.H., Chen T.F., Sheu J.R. Alpha-Naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation. Journal of Agriculture and Food Chemistry 2005, 53:5179-5186.
46. Hsiao G., Chou P.H., Shen M.Y., Chou D.S., Lin C.H., Sheu J.R. C-phycocyanin, a very potent and novel platelet aggregation inhibitor from Spirulina platensis. Journal of Agriculture and Food Chemistry 2005, 53:7734-7740.
47. Hu F.B. Plant-based foods and prevention of cardiovascular disease: an overview. American Journal of Clinical Nutrition 2003, 78:544S-551S.
48. Im J.H., Jin Y.R., Lee J.J., Yu J.Y., Han X.H., Im S.H., Hong J.T., Yoo H.S., Pyo M.Y., Yun Y.P. Antiplatelet activity of beta-carboline alkaloids from Perganum harmala: A possible mechanism through inhibiting PLCgamma2 phosphorylation. Vascular Pharmacology 2009, 50:147-152.
49. Jayakumar T., Chen W.F., Lu W.J., Chou D.S., Hsiao G., Hsu C.Y., Sheu J.R., Hsieh C.Y. A novel antithrombotic effect of sulforaphane via activation of platelet adenylate cyclase: ex vivo and in vivo studies. Journal of Nutritional Biochemistry 2012.
50. Jeng J.H., Wu H.L., Lin B.R., Lan W.H., Chang H.H., Ho Y.S., Lee P.H., Wang Y.J., Wang J.S., Chen Y.J., Chang M.C. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production. Atherosclerosis 2007, 191:250-258.
51. Jensen B.O., Selheim F., Doskeland S.O., Gear A.R., Holmsen H. Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxide. Blood 2004, 104:2775-2782.
52. Jin Y.R., Han X.H., Zhang Y.H., Lee J.J., Lim Y., Chung J.H., Yun Y.P. Antiplatelet activity of hesperetin, a bioflavonoid, is mainly mediated by inhibition of PLC-gamma2 phosphorylation and cyclooxygenase-1 activity. Atherosclerosis 2007, 194:144-152.
53. Jin Y.R., Im J.H., Park E.S., Cho M.R., Han X.H., Lee J.J., Lim Y., Kim T.J., Yun Y.P. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity. Journal of Cardiovascular Pharmacology 2008, 51:45-54.
54. Kim S.H., Jun C.D., Suk K., Choi B.J., Lim H., Park S., Lee S.H., Shin H.Y., Kim D.K., Shin T.Y. Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicological Sciences 2006, 91:123-131.
55. Kim B.J., Kim Y.K., Park W.H., Ko J.H., Lee Y.C., Kim C.H. A water-extract of the Korean traditional formulation Geiji-Bokryung-Hwan reduces atherosclerosis and hypercholesteremia in cholesterol-fed rabbits. International Immunopharmacology 2003, 3:723-734.
56. Kim K., Lim K.M., Kim C.W., Shin H.J., Seo D.B., Lee S.J., Noh J.Y., Bae O.N., Shin S., Chung J.H. Black soybean extract can attenuate thrombosis through inhibition of collagen-induced platelet activation. Journal of Nutritional Biochemistry 2011, 22:964-970.
57. Knight W., Yan C. Therapeutic potential of PDE modulation in treating heart disease. Future Medicinal Chemistry 2013, 5:1607-1620.
58. Ko F.N., Lee Y.S., Wu T.S., Teng C.M. Inhibition of cyclooxygenase activity and increase in platelet cyclic AMP by girinimbine, isolated from Murraya euchrestifolia. Biochemical Pharmacology 1994, 48:353-360.
59. Ko W.C., Shih C.M., Lai Y.H., Chen J.H., Huang H.L. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships. Biochemical Pharmacology 2004, 68:2087-2094.
60. Kondo K., Suzuki Y., Ikeda Y., Umemura K. Genistein, an isoflavone included in soy, inhibits thrombotic vessel occlusion in the mouse femoral artery and in vitro platelet aggregation. European Journal of Pharmacology 2002, 455:53-57.
61. Lai Y.S., Shih C.Y., Huang Y.F., Chou T.C. Antiplatelet activity of alpha-lipoic acid. Journal of Agriculture and Food Chemistry 2010, 58:8596-8603.
62. Lee J.J., Jin Y.R., Lim Y., Hong J.T., Kim T.J., Chung J.H., Yun Y.P. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization. Vascular Pharmacology 2006, 45:148-153.
63. Leoncini G., Signorello M.G., Bruzzese D., Di Braccio M., Grossi G.C., Roma G. Mechanisms involved in the antiplatelet activity of 8-methyl-4-(1-piperazinyl)-7-(3-pyridinylmethoxy)-2H-1-benzopyran-2-one (RC414). Biochemical Pharmacology 2004, 67:911-918.
64. Levesque L., Crooke S.T. Depletion of protein kinase C-alpha by antisense oligonucleotides alters beta-adrenergic function and reverses the phorbol ester-induced reduction of isoproterenol-induced adenosine 3'-5'-cyclic monophosphate accumulation in murine Swiss 3T3 fibroblasts. Journal of Pharmacology and Experimental Therapeutics 1998, 287:425-434.
65. Li P.G., Sun L., Han X., Ling S., Gan W.T., Xu J.W. Quercetin induces rapid eNOS phosphorylation and vasodilation by an Akt-independent and PKA-dependent mechanism. Pharmacology 2012, 89:220-228.
66. Liao C.H., Ko F.N., Wu C.L., Teng C.M. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets. Journal of Pharmacy and Pharmacology 2000, 52:353-359.
67. Lin K.H., Kuo J.R., Lu W.J., Chung C.L., Chou D.S., Huang S.Y., Lee H.C., Sheu J.R. Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo. Biochemical Pharmacology 2013, 85:1478-1485.
68. Lockhart L.K., Pampolina C., Nickolaychuk B.R., McNicol A. Evidence for a role for phospholipase C, but not phospholipase A2, in platelet activation in response to low concentrations of collagen. Thrombosis and Haemostasis 2001, 85:882-889.
69. Macakova K., Rehakova Z., Mladenka P., Karlickova J., Filipsky T., Riha M., Prasad A.K., Parmar V.S., Jahodar L., Pavek P., Hrdina R., Saso L. In vitro platelet antiaggregatory properties of 4-methylcoumarins. Biochimie 2012, 94:2681-2686.
70. Makheja A.N., Bailey J.M. Antiplatelet constituents of garlic and onion. Agents and Actions 1990, 29:360-363.
71. Manaster Y., Shenkman B., Rosenberg N., Savion N. Allicin and disulfiram enhance platelet integrin alphaIIbbeta3-fibrinogen binding. Thrombosis Research 2009, 124:477-482.
72. Manns J.M., Brenna K.J., Colman R.W., Sheth S.B. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases. Thrombosis and Haemostasis 2002, 87:873-879.
73. Matetzky S., Shenkman B., Guetta V., Shechter M., Beinart R., Goldenberg I., Novikov I., Pres H., Savion N., Varon D., Hod H. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation 2004, 109:3171-3175.
74. McNicol A. The effects of genistein on platelet function are due to thromboxane receptor antagonism rather than inhibition of tyrosine kinase. Prostaglandins Leukotrienes and Essential Fatty Acids 1993, 48:379-384.
75. Michelson A.D. Platelet function testing in cardiovascular diseases. Circulation 2004, 110:e489-493.
76. Minamino T., Kitakaze M., Asanuma H., Tomiyama Y., Shiraga M., Sato H., Ueda Y., Funaya H., Kuzuya T., Matsuzawa Y., Hori M. Endogenous adenosine inhibits P-selectin-dependent formation of coronary thromboemboli during hypoperfusion in dogs. Journal of Clinical Investigation 1998, 101:1643-1653.
77. Mirmiran P., Bahadoran Z., Hosseinpanah F., Keyzad A., Azizi F. Effects of broccoli sprout with high sulforaphane concentration on inflammatory markers in type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial. Journal of Functional Foods 2012, 4:837-841.
78. Mladenka P., Zatloukalova L., Filipsky T., Hrdina R. Cardiovascular effects of flavonoids are not caused only by direct antioxidant activity. Free Radical Biology and Medicine 2010, 49:963-975.
79. Munoz Y., Garrido A., Valladares L. Equol is more active than soy isoflavone itself to compete for binding to thromboxane A(2) receptor in human platelets. Thrombosis Research 2009, 123:740-744.
80. Murohara T., Ikeda H., Otsuka Y., Aoki M., Haramaki N., Katoh A., Takajo Y., Imaizumi T. Inhibition of platelet adherence to mononuclear cells by alpha-tocopherol: Role of P-selectin. Circulation 2004, 110:141-148.
81. Murray R., FitzGerald G.A. Regulation of thromboxane receptor activation in human platelets. Proceedings of the National Academy of Sciences USA 1989, 86:124-128.
82. Navarro-Nunez L., Lozano M.L., Palomo M., Martinez C., Vicente V., Castillo J., Benavente-Garcia O., Diaz-Ricart M., Escolar G., Rivera J. Apigenin inhibits platelet adhesion and thrombus formation and synergizes with aspirin in the suppression of the arachidonic acid pathway. Journal of Agriculture and Food Chemistry 2008, 56:2970-2976.
83. Navarro-Nunez L., Rivera J., Guerrero J.A., Martinez C., Vicente V., Lozano M.L. Differential effects of quercetin, apigenin and genistein on signalling pathways of protease-activated receptors PAR(1) and PAR(4) in platelets. British Journal of Pharmacology 2009, 158:1548-1556.
84. Oestreich J. SCH-530348, a thrombin receptor (PAR-1) antagonist for the prevention and treatment of atherothrombosis. Current Opinion in Investigational Drugs 2009, 10:988-996.
85. Oh W.J., Endale M., Park S.C., Cho J.Y., Rhee M.H. Dual roles of quercetin in platelets: Phosphoinositide-3-kinase and MAP kinases inhibition, and cAMP-dependent vasodilator-stimulated phosphoprotein stimulation. Evidence-Based Complementary and Alternative Medicine 2012, 2012:485262.
86. Ok W.J., Cho H.J., Kim H.H., Lee D.H., Kang H.Y., Kwon H.W., Rhee M.H., Kim M., Park H.J. Epigallocatechin-3-gallate has an anti-platelet effect in a cyclic AMP-dependent manner. Journal of Atherosclerosis Thrombosis 2012, 19:337-348.
87. Okamoto K., Horisawa R. Soy products and risk of an aneurysmal rupture subarachnoid hemorrhage in Japan. European Journal of Cardiovascular Prevention and Rehabilitation 2006, 13:284-287.
88. O'Kennedy N., Crosbie L., van Lieshout M., Broom J.I., Webb D.J., Duttaroy A.K. Effects of antiplatelet components of tomato extract on platelet function in vitro and ex vivo: A time-course cannulation study in healthy humans. American Journal of Clinical Nutrition 2006, 84:570-579.
89. Ostertag L.M., O'Kennedy N., Horgan G.W., Kroon P.A., Duthie G.G., de Roos B. In vitro anti-platelet effects of simple plant-derived phenolic compounds are only found at high, non-physiological concentrations. Molecular Nutrition & Food Research 2011, 55:1624-1636.
90. Palomo I., Fuentes E., Padro T., Badimon L. Platelets and atherogenesis: Platelet anti-aggregation activity and endothelial protection from tomatoes (Solanum lycopersicum L.). Exp Ther Med 2012, 3:577-584.
91. Park J.B. N-coumaroyldopamine and N-caffeoyldopamine increase cAMP via beta 2-adrenoceptors in myelocytic U937 cells. FASEB Journal 2005, 19:497-502.
92. Park W.H., Kim S.H., Chang Y.C., Lee Y.C., Kim C.H. The antiplatelet activity of Danggijakyaksan by inhibition of phospholipase C. Immunopharmacology and Immunotoxicology 2003, 25:561-571.
93. Park W.H., Kim K.S., Kim K.H., Kim D.S., Kim C.H. The antiplatelet activity of Geiji-Bokryung-Hwan, Korean traditional formulation, is mediated through inhibition of phospholipase C and inhibition of TxB(2) synthetase activity. International Immunopharmacology 2003, 3:971-978.
94. 2+ mobilization in activated human platelets. Life Sciences 2004, 75:3063-3076.
95. Park E.S., Lim Y., Lee S.H., Kwon B.M., Yoo H.S., Hong J.T., Yun Y.P. Antiplatelet activity of obovatol, a biphenolic component of Magnolia Obovata, in rat arterial thrombosis and rabbit platelet aggregation. Journal of Atherosclerosis Thrombosis 2011, 18:659-669.
96. Park J.B., Schoene N. Clovamide-type phenylpropenoic acid amides, N-coumaroyldopamine and N-caffeoyldopamine, inhibit platelet-leukocyte interactions via suppressing P-selectin expression. Journal of Pharmacology and Experimental Therapeutics 2006, 317:813-819.
97. Petroni A., Blasevich M., Salami M., Papini N., Montedoro G.F., Galli C. Inhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil. Thrombosis Research 1995, 78:151-160.
98. Pierre S., Crosbie L., Duttaroy A.K. Inhibitory effect of aqueous extracts of some herbs on human platelet aggregation in vitro. Platelets 2005, 16:469-473.
99. Plaza M., Cifuentes A., Ibañez E. In the search of new functional food ingredients from algae. Trends in Food Science & Technology 2008, 19:31-39.
100. Qi R., Liao F., Inoue K., Yatomi Y., Sato K., Ozaki Y. Inhibition by diallyl trisulfide, a garlic component, of intracellular Ca(2+) mobilization without affecting inositol-1,4, 5-trisphosphate (IP(3)) formation in activated platelets. Biochemical Pharmacology 2000, 60:1475-1483.
101. Ramadan M.F., Al-Ghamdi A. Bioactive compounds and health-promoting properties of royal jelly: A review. Journal of Functional Foods 2012, 4:39-52.
102. Ridker P.M., Cook N.R., Lee I.M., Gordon D., Gaziano J.M., Manson J.E., Hennekens C.H., Buring J.E. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. New England Journal of Medicine 2005, 352:1293-1304.
103. Roberfroid M.B. Inulin-type fructans: Functional food ingredients. Journal of Nutrition 2007, 137:2493S-2502S.
104. Rosado J.A., Porras T., Conde M., Sage S.O. Cyclic nucleotides modulate store-mediated calcium entry through the activation of protein-tyrosine phosphatases and altered actin polymerization in human platelets. Journal of Biological Chemistry 2001, 276:15666-15675.
105. Sabha D., Hiyasat B., Grotzinger K., Hennig L., Schlegel F., Mohr F.W., Rauwald H.W., Dhein S. Allium ursinum L.: Bioassay-guided isolation and identification of a galactolipid and a phytosterol exerting antiaggregatory effects. Pharmacology 2012, 89:260-269.
106. 2+ signaling. Biochemical Pharmacology 1999, 58:1167-1172.
107. Shashidhar M.G., Giridhar P., Udaya Sankar K., Manohar B. Bioactive principles from Cordyceps sinensis: A potent food supplement â€" a review. Journal of Functional Foods 2013, 5:1013-1030.
108. Shen M.Y., Hsiao G., Liu C.L., Fong T.H., Lin K.H., Chou D.S., Sheu J.R. Inhibitory mechanisms of resveratrol in platelet activation: Pivotal roles of p38 MAPK and NO/cyclic GMP. British Journal of Haematology 2007, 139:475-485.
109. Shen M.Y., Liu C.L., Hsiao G., Liu C.Y., Lin K.H., Chou D.S., Sheu J.R. Involvement of p38 MAPK phosphorylation and nitrate formation in aristolochic acid-mediated antiplatelet activity. Planta Medica 2008, 74:1240-1245.
110. Shen C.C., Ni C.L., Shen Y.C., Huang Y.L., Kuo C.H., Wu T.S., Chen C.C. Phenolic constituents from the stem bark of Magnolia officinalis. Journal of Natural Products 2009, 72:168-171.
111. Sheu J.R., Hsiao G., Chou P.H., Shen M.Y., Chou D.S. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets. Journal of Agriculture and Food Chemistry 2004, 52:4414-4418.
112. Sheu J.R., Hsiao G., Shen M.Y., Chou C.Y., Lin C.H., Chen T.F., Chou D.S. Inhibitory mechanisms of kinetin, a plant growth-promoting hormone, in platelet aggregation. Platelets 2003, 14:189-196.
113. Sheu J.R., Kan Y.C., Hung W.C., Su C.H., Lin C.H., Lee Y.M., Yen M.H. The antiplatelet activity of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, is mediated through inhibition of phospholipase C. Thrombosis Research 1998, 92:53-64.
114. Shih C.Y., Chou T.C. The antiplatelet activity of magnolol is mediated by PPAR-beta/gamma. Biochemical Pharmacology 2012, 84:793-803.
115. Siddiqui A.M., Cui X., Wu R., Dong W., Zhou M., Hu M., Simms H.H., Wang P. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma. Critical Care Medicine 2006, 34:1874-1882.
116. Smyth S.S., Woulfe D.S., Weitz J.I., Gachet C., Conley P.B., Goodman S.G., Roe M.T., Kuliopulos A., Moliterno D.J., French P.A., Steinhubl S.R., Becker R.C. G-protein-coupled receptors as signaling targets for antiplatelet therapy. Arteriosclerosis, Thrombosis, and Vascular Biology 2009, 29:449-457.
117. Srivastava K.C., Bordia A., Verma S.K. Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostaglandins Leukotrienes and Essential Fatty Acids 1995, 52:223-227.
118. Stone W.L., Krishnan K., Campbell S.E., Qui M., Whaley S.G., Yang H. Tocopherols and the treatment of colon cancer. Annals of the New York Academy of Sciences 2004, 1031:223-233.
119. Torres-Urrutia C., Guzman L., Schmeda-Hirschmann G., Moore-Carrasco R., Alarcon M., Astudillo L., Gutierrez M., Carrasco G., Yuri J.A., Aranda E., Palomo I. Antiplatelet, anticoagulant, and fibrinolytic activity in vitro of extracts from selected fruits and vegetables. Blood Coagulation & Fibrinolysis 2011, 22:197-205.
120. Voa Thanh-Sang, Kim Se-Kwon Fucoidans as a natural bioactive ingredient for functional foods. Journal of Functional Foods 2013, 5:16-27.
121. Wang Y., Wang J., Guo L., Gao X. Antiplatelet effects of qishen yiqi dropping pill in platelets aggregation in hyperlipidemic rabbits. Evidence-Based Complementary and Alternative Medicine 2012, 2012:205451.
122. Willoughby S., Holmes A., Loscalzo J. Platelets and cardiovascular disease. European Journal of Cardiovascular Nursing 2002, 1:273-288.
123. Wright B., Moraes L.A., Kemp C.F., Mullen W., Crozier A., Lovegrove J.A., Gibbins J.M. A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids. British Journal of Pharmacology 2010, 159:1312-1325.
124. Xia Q., Wang X., Xu D.J., Chen X.H., Chen F.H. Inhibition of platelet aggregation by curdione from Curcuma wenyujin essential oil. Thrombosis Research 2012, 130:409-414.
125. Yin X.Z., Quan J.S., Takemichi K., Makoto T. Anti-atherosclerotic effect of soybean isofalvones and soyasaponins in diabetic rats. Zhonghua Yu Fang Yi Xue Za Zhi 2004, 38:26-28.
126. Yokoi H., Mizukami H., Nagatsu A., Tanabe H., Inoue M. Hydroxy monounsaturated fatty acids as agonists for peroxisome proliferator-activated receptors. Biological & Pharmaceutical Bulletin 2010, 33:854-861.
127. Zhang W., Colman R.W. Thrombin regulates intracellular cyclic AMP concentration in human platelets through phosphorylation/activation of phosphodiesterase 3A. Blood 2007, 110:1475-1482.
128. Zhang L., Gu Z.L., Qin Z.H., Liang Z.Q. Effect of curcumin on the adhesion of platelets to brain microvascular endothelial cells in vitro. Acta Pharmacologica Sinica 2008, 29:800-807.
129. Zhang X., Shu X.O., Gao Y.T., Yang G., Li Q., Li H., Jin F., Zheng W. Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. Journal of Nutrition 2003, 133:2874-2878.
130. Zhong Y., Ma C.-M., Shahidi F. Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives. Journal of Functional Foods 2012, 4:87-93.
131. Zoungas S., McGrath B.P., Branley P., Kerr P.G., Muske C., Wolfe R., Atkins R.C., Nicholls K., Fraenkel M., Hutchison B.G., Walker R., McNeil J.J. Cardiovascular morbidity and mortality in the atherosclerosis and folic acid supplementation trial (ASFAST) in chronic renal failure: A multicenter, randomized, controlled trial. Journal of the American College of Cardiology 2006, 47:1108-1116.